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ABSTRACT* 
Background: During recent years mobile technology has 
developed tremendously and has infiltrated the healthcare 
field. Mobile healthcare (mHealth) applications, or apps, 
may be used to support patient adherence to medication 
thus promoting optimal treatment outcomes and reducing 
medication wastage.  
Objective: This study shall consider the opinions of United 
Kingdom (UK) based pharmacists, pharmacy 
undergraduates and members of the general public 
towards the use of mHealth apps to promote adherence to 
prescribed medication regimens. 
Methods: On Liverpool John Moores University (LJMU) 
ethical approval, the 25 item questionnaire was distributed 
to UK registered pharmacists within inner city Liverpool 
and Manchester (n=500), pharmacy undergraduates 
studying at LJMU (n=420) and members of the general 
public within Liverpool City Centre (n=400). The questions 
were formatted as multiple choice, Likert scales or the 
open answer type. The data were analysed using simple 
frequencies, cross tabulations and non-parametric 
techniques in the SPSS v22 program. 
Results: The number of completed questionnaires from 
the pharmacist, student and general public cohorts were 
245, 333 and 400; respectively. The data indicated that the 
general public rely heavily upon daily routine to take 
medication as prescribed (54.1%) with mHealth app use 
being extremely low (1.5%); a similar trend was noted for 
the pharmacist / student cohorts. The age of the individual 
is an important consideration, with the younger generation 
likely to engage with mHealth apps and the older 
generation less so. Here, education and training are 
important. Pharmacists (82.3%) would be happy to deliver 
training packages to the public who would in turn happily 
receive such training (84%). Key barriers precluding 
mHealth app use include data reliability, security and 
technical difficulties.  
Conclusion: Adherence apps hold great promise to 
support the patient and their healthcare needs. In order to 
increase acceptance and uptake simple, user-friendly 
designs must be considered and constructed. In addition, 
such technology requires effective promotion and end user 
training in order to reach its full potential. Furthermore, the 
regulation of mobile adherence apps will be essential in 
order to overcome underlying patient concerns.  
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INTRODUCTION 
Mobile technology has advanced significantly over 
the course of the previous decade. Within recent 
years this form of technology has undergone major 
improvements in terms of processor speed, memory 
and storage capacity along with battery life. 
Furthermore, operating systems have become more 
efficient thus enabling the execution of multiple 
tasks including Internet access.1 Mobile telephones 
that meet such specifications are now referred to as 
‘smartphones’.2 In a similar manner, tablet devices 
(i.e. larger versions of smartphones with a similar 
feature set) have also become exceedingly popular. 
Software applications (i.e. ‘apps’) are essential 
drivers for all mobile devices.3 Mobile apps have 
infiltrated into society through services including 
gaming, social networking, news, education and 
healthcare. As previously reported3, the rapid 
evolution of software platforms on advanced mobile 
devices over the past decade has paved the way for 
mobile healthcare (mHealth) apps, which have 
seamlessly infiltrated healthcare systems in the 
developed world.1 At present, thousands of mHealth 
apps are available4,5 and include for example ‘Dario’ 
and ‘MyMeds’.6,7 Naturally, the scope of mHealth 
apps in patient care is huge. For instance, the 
software packages can aid the diagnosis process, 
enable effective patient monitoring, provide medical 
information and even serve as a communication tool 
between patients and healthcare professionals.1 
More recently, remote diagnosis has become a 
popular trend within the field of mHealth. A prime 
example involves the development of a mobile 
healthcare app which allows the general public to 
take photographs of their skin conditions, with the 
image being sent to a dermatologist for analysis. In 
2012, Borve and co-workers reviewed the viability of 
this concept in which 40 patients sent photographs 
of their skin conditions (e.g. cancer) to 
dermatologists for diagnosis and treatment advice.5 
It was noted that the dermatologists assessing the 
photographs had an accuracy concordance of 68%. 
Clearly, mHealth apps provide the opportunity to 
support the patient (e.g. their adherence to 
medication regimens) and ultimately improve quality 
of life. 
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Patient adherence to medication regimens 
The term ‘adherence’ refers to the extent to which a 
patient takes their medication as agreed with their 
prescriber.8-10 Aspects that might impact upon this 
include the dose, timing, frequency and duration of 
the treatment.4 Medication non-adherence is 
prevalent within developed countries (i.e. the United 
Kingdom (UK) and the United States of America 
(USA)).11 This particular issue within healthcare is 
becoming increasingly significant, with recent UK 
estimates suggesting that a third to a half of 
prescribed medication is not used as intended.12 
Net effects include poor therapeutic outcomes, 
increased hospital admissions along with 
medication wastage.13 Clearly, such negative 
aspects can place huge financial burdens on 
healthcare providers. For example, in 2010 the UK-
based National Health Service (NHS) estimated that 
non-adherence to prescribed medication resulted in 
the loss of GBP 500 million from their system.14 
Patient non-adherence to prescribed medication 
regimens may be broadly described as either 
intentional or unintentional.8 The former involves the 
patient deciding that they do not wish to use their 
medication in the way that was agreed between 
themselves and the prescriber. This may be 
ascribed to the individual experiencing adverse drug 
reactions, holding a poor perception of health 
benefits and confusion due to regimen complexity.4 
Unintentional non-adherence differs slightly in that 
the patient is willing to take their medication as 
agreed but fails to do so, possibly due to 
forgetfulness and complexities of daily life.8,15-18  
The ability to communicate with healthcare 
professionals via mHealth platforms could offer an 
effective means by which to resolve issues with 
medication that can lead to unintentional non-
adherence. For example, the technology could be 
applied to track a patient’s health status on a daily 
basis such that the extent of their symptoms or side 
effects (i.e. blood pressure, heart-rate or blood 
glucose levels) may be monitored. Related 
documentation and educational approaches could 
make health benefits clearer to patients and better 
support their needs. Indeed, mHealth can be helpful 
in making complex drug regimens seem 
straightforward and easier to manage thus making 
the patient feel less overwhelmed and more likely to 
take their medication as prescribed thus overcoming 
elements relating to unintentional non-adherence.  
To date, positive steps have been taken within the 
UK to remedy this pressing situation. However, true 
adherence is challenging to both monitor and 
measure.4 All methods to aid adherence to 
medication (i.e. the use of traditional pill boxes) 
have limitations. For example, patient feedback is 
likely to be inaccurate due to bias and memory 
defects8, the direct observation of medicine 
administration is often impractical and in terms of 
blister packs, supply counts and repeat prescription 
rates do not confirm that the patient has actually 
taken the medication prescribed.8 
The most common type of behavioural intervention 
is through reminder systems, which can involve 
various prompts through notes, diaries, alarms or 
advanced pill boxes.19 Text messages and text 
messages requiring a response have been utilised 
in order to improve adherence and results have 
shown positive short-term outcomes after six 
months.20 Nevertheless, the effect of long-term use 
is less clear and it may be that text-message 
reminders are only suitable for short-courses of 
drug treatment as opposed to managing chronic 
conditions. 
Service driven initiatives are now firmly established 
within the community pharmacy setting with the aim 
of educating and empowering the patient; hence 
offering potential to overcome the drawbacks 
associated with the more traditional routes of 
adherence support. Here, the pharmacist is able to 
conduct medicines use reviews (MURs) and deliver 
the new medicines service (NMS) in order to 
underscore the importance / use of prescribed 
medication and why it is imperative to take 
medication as prescribed.3 Notwithstanding the 
success of such advanced services, scope now 
exists to exploit mobile technology platforms along 
with app-based software to support the patient in 
following daily treatment plans to optimise treatment 
outcomes. 
At present mHealth is an emerging concept within 
developed countries and is not positioned directly at 
the forefront of healthcare service provision.3 
Typically, workplace activities within a community 
pharmacy premises in the UK involve prescription 
dispensing, over-the-counter sales and the 
provision of related advice plus services such as 
blood pressure monitoring. There is great potential, 
however, for mHealth apps to support the 
pharmacist in daily activities, as mentioned herein, 
and offer support to the patient to derive the 
maximum benefit from prescribed / purchased 
medication regimens. Over time there is real 
potential for the integration of the more traditional 
mechanisms of healthcare delivery supported with 
mHealth apps and related advanced technologies in 
the delivery of healthcare to the public. 
Mobile healthcare apps to support patient 
adherence to medication regimens 
Mobile healthcare applications offer an innovative 
means by which to improve patient adherence to 
medication, thus negating the problems associated 
with non-adherence. This form of technology is 
particularly valuable to patients with complex 
medication regimens and those with cognitive 
impairment along with carers.8 Such mHealth apps 
may be utilised to remind patients when to take their 
medication. Here, the more straightforward mHealth 
apps (i.e. RxmindMe21) are able to provide 
individuals with reminder notices as to when the 
dose is due and additionally have the capacity to 
record when the dose is taken. Such apps can 
provide information about medicinal products, 
including special instructions from healthcare 
providers and can also monitor physiological 
parameters.8 Although there is great potential for 
mHealth apps to serve as reminder points for 
dosing regimens, the software does fail to address 
aspects such as educational barriers and health 
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literacy amongst a population. Aspects such as 
these may be overcome with service driven support 
mechanisms within the community pharmacy 
setting, as noted above, such that the patient is 
clear on why their medication is prescribed and the 
associated dosing schedules.  
An excellent example of a more advanced system is 
that of SmartTrack, a novel device that aims to 
improve patient adherence to inhaler devices. This 
platform works by clipping onto inhaler devices, 
such that when a patient inserts the inhaler to take a 
dose, the unit records the date and time and 
uploads the data onto a website which can also be 
accessed via an app. The product can also send 
reminder messages if a dose is missed. The 
potential of this particular adherence app was 
investigated by Foster and co-workers in 2014.22 
Here, a randomised controlled trial was conducted 
in a primary care setting and involved 143 patients 
with inadequate asthma control, who were 
prescribed a control inhaler for twice daily use. The 
data indicated that after a period of six months had 
elapsed the SmartTrack users showed significantly 
higher levels of medication adherence (i.e. 73% vs 
46%).  
In relation to this point, Propeller Health has 
recently devised a sensor technology called 
Propeller Sensor that is capable of recording the 
time and location of inhaler use.23 The sensor is 
able to connect to a mobile device and capture data 
that can be applied to monitor both usage and 
inhaler technique. The information acquired may be 
applied to educate the patient on how best to use 
the inhaled dosage form. An important feature with 
the mHealth app-based approach involves the 
capacity to monitor the frequency of drug 
administration with global position in mind. Here, 
scope exists to link the onset of an asthma attack 
directly with the immediate environment. The 
information gained may be used as an avoidance 
strategy for further asthma attacks. 
The development of smartphone / tablet devices 
has inevitably led to the integration of healthcare 
apps with external physical biosensors, which may 
allow for the monitoring of patient adherence to 
prescribed regimens.14,24 Such biosensors may take 
the form of solid oral dosage forms or ‘smart 
patches’, for example. In any case, the units have 
embedded technology to ‘read’ vital signs 
associated with administration and bodily function. 
A good example of this approach is the ‘Helius’ 
platform that provides opportunity to track 
medication usage (i.e. via oral administration) using 
a sensor-enabled inactive tablet.25 Here, the 
technology relies upon a biosensor that is 
embedded into a mock oral dosage form. The 
sensor is able to transmit two signals, one to a 
wearable patch once in contact with electrolytes in 
gastric fluid and another to the mobile device 
displaying the time and date that medicine was 
ingested.26 In this way, the feedback system can 
monitor when a particular dose has been taken and 
the information can be relayed to the prescriber for 
monitoring purposes. In addition, scope exists to 
obtain physiologically relevant information (i.e. heart 
rate and blood pressure) via an accompanying 
smart patch worn by the patient. Clearly, this form of 
novel technology can assist patients who cannot 
remember if they have taken their medication (i.e. 
via reminder messages) and can also be used by 
family members to monitor the patient. In principle, 
this approach does show promise as demonstrated 
by Belknap and colleagues in 2013.27 Here, the 
group conducted a small scale study that involved 
30 tuberculosis patients in the age range of 22 and 
79 years. The data indicated that 83% of the 
patients showed high levels of comfort with the 
Helius technology and indeed 75% would be 
content with using it permanently. 
Concerns with healthcare apps 
Although mobile apps demonstrate promise to 
support healthcare many concerns have been 
aired.28 For example, limited regulation may lead to 
apprehension over accuracy, reliability and the 
evidence-base for information provided.3 In addition, 
concerns surrounding the extent of medical training 
of the app developers have been highlighted.28 An 
important concern revolves around usability, 
particularly with the older generation who may be 
unfamiliar using such programmes.29 However, in 
terms of this latter point, recent research indicates 
that the older generation may be slowly embracing 
developments in the mHealth field30; which will be 
an emerging trend as the younger generation ages.3 
To illustrate this point, Parker and co-workers have 
recently considered the opinions of 41 patients aged 
60 and over with chronic pain in the USA towards 
the use of mHealth apps; with only a small 
proportion of the study group had previously used a 
mHealth app.30 The data suggested that the 
majority of participants (i.e. 85%) were enthusiastic 
about the use of mHealth apps to assist with pain 
management. Furthermore, participants discussed 
important barriers to preclude the use of mHealth 
apps (i.e. concerns about privacy) and methods by 
which to enhance uptake (i.e. training). 
With respect to healthcare provision, a key area for 
consideration would be the balance between the 
time taken for mHealth app use and the direct 
benefit to the unfolding clinical scenario. This point 
was alluded to by Kamel Boulos and colleagues in 
2014, who suggested that in a time critical situation 
mHealth apps may play an important role should 
speed and accessibility be required.31 The 
examples provided by the group were those of 
stroke or acute trauma. However, in a similar way 
the pharmacist located within the community 
setting, or indeed the hospital setting, may at some 
stage require fast and ready access to medical 
information to manage an unfolding situation within 
their practice. 
Research purpose 
Over the course of recent years mobile apps have 
significantly influenced the way in which people go 
about their daily lives; including how they manage 
their health. A number of current studies within the 
field consider the variety of adherence apps that are 
available for use to support healthcare within more 
developed countries. However, to date, there is 
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limited research that considers the thoughts of 
pharmacy undergraduate students, qualified 
pharmacists and members of the general public 
regarding the use of such apps in aiding medication 
adherence. These groups are of particular interest 
as they are, in their own particular way, ultimately 
involved with medication supply and usage. The 
perceptions of pharmacy students, pharmacists and 
the general public towards the use of mHealth apps 
for medication adherence are important so as to 
note whether the technology platforms can be of 
real value within the sphere of healthcare delivery in 
the (near) future. We suggest that it is indeed timely 
to investigate whether mobile apps may be applied 
to support medication adherence from both a 
professional and end-user perspective.  
 
METHODS  
Questionnaire preparation and ethical approval 
At the outset, a comprehensive literature review 
was conducted in order to fully understand current 
opinion surrounding the field of mHealth. This 
process involved an intensive period of investigation 
of peer-reviewed journal articles and Internet-based 
assets that closely aligned with mHealth app use in 
the field of healthcare. Overall, our assessment 
indicated that themes of importance were the use of 
technology in healthcare, the increased popularity of 
self-care among the public, various forms of 
adherence interventions and the suitability of using 
mobile apps over more traditional options and 
obstructions that could counteract the use of mobile 
apps. These topics were listed and subsequently a 
number of questions were formulated linking to the 
recurrent themes. To this end, the understanding 
gained was utilised to inform the questions posed 
during the study; example questions included:  
1. To what extent do you feel confident in 
managing your own medication? 
2. How likely would you be to use mobile 
healthcare apps over consulting a healthcare 
professional? 
3. To what extent would you use a mobile app to 
help with your adherence to medication? 
4. To what extent would feel confident in using a 
mobile app to help aid adherence if promoted by 
a healthcare professional? 
5. To what extent is it important for you that mobile 
healthcare apps are regulated by a professional 
body? 
6. How happy would you be to receive training on 
how to use a mobile health application from your 
healthcare professional? 
The questions were formulated appropriately to 
target the pharmacist, pharmacy students and the 
general public cohorts. To achieve this 
consideration was given to the roles of healthcare 
provider and end-user: 
1. Pharmacist opinion on the usefulness / barriers 
of mHealth apps to support patient adherence / 
healthcare 
2. The opinions of students as to how useful 
mHealth apps might be to support patient 
adherence / healthcare 
3. The way in which the general public (i.e. 
patients) view mHealth apps to support 
medication adherence 
The questionnaire featured Likert statements (i.e. 
strongly agree, agree, neither agree nor disagree, 
disagree, strongly disagree) and ‘free-text’ boxes to 
develop a deeper understanding of participant 
views. The questionnaire contained five sections: 
(1) Background information, (2) Self-care, (3) 
Medication adherence, (4) Usability and (5) 
Demographics. Further to completion of the 
questionnaire and support materials (i.e. cover letter 
and participant information sheet), ethical approval 
was sought and obtained by the Liverpool John 
Moores University Research Ethics Committee 
(LJMU REC).  
Questionnaire distribution  
During January and February 2015, the 
questionnaire packs were distributed to 420 
MPharm undergraduate students enrolled at LJMU, 
500 community pharmacies located within inner city 
Liverpool and Manchester along with 400 members 
of the general public within Liverpool City Centre. 
The sample size of each cohort was chosen due to 
time and resource restrictions. As the study period 
totalled 6 weeks, an appropriate number of 
participants were chosen for each cohort. In 
addition, the size of the study was limited with the 
budget available for printing and distributing the 
questionnaires. In the case of the general public 
cohort, the questionnaire was completed at the 
initial point of contact and remained anonymous 
throughout. The inclusion criteria involved the 
following: any individual who was willing to 
participate; but did not include pharmacists, 
pharmacy staff, healthcare students, anyone under 
the age of 18 or vulnerable adults who were unable 
to give consent. Here, participants were approached 
at different times in the day in an attempt to target 
various people and to achieve an accurate 
representation of the local population. 
The pack consisted of a 25 item questionnaire, a 
covering letter, a participant information leaflet as 
well as an A5 freepost response envelope for 
document return and confirmation of consent (i.e. in 
the case of the pharmacist cohort). At all times the 
information remained confidential. The 
questionnaires were coded for tracking purposes 
and all codes were held securely. In an attempt to 
improve the response rate, follow up telephone calls 
were made to those pharmacies who did not 
respond after two weeks of receiving the 
questionnaire; if necessary, the questionnaire 
completed over the telephone or another 
questionnaire pack dispatched if requested. The 
data were not analysed with the codes as 
references. The codes were used solely to track the 
position of the response rate over time and for 
subsequent follow up. 
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Statistical analysis 
The data obtained were processed and analysed 
via the Statistical Package for the Social Sciences 
(SPSS) v22 software package. All data were 
validated via double inspection. To provide an 
overview of trends within the data, the analysis 
included descriptive procedures such as 
frequencies on each variable. Bivariate procedures 
such as cross tabulations, Mann-Whitney tests and 
Kruskal-Wallis tests were used to observe 
associations between different groups. P-values 
were calculated with statistical significance only if 
the p-value was less than or equal to 0.05 which 
implies that there was a 95% confidence in the 
analysis. 
 
RESULTS  
Demographics 
Overall, 420 questionnaires were distributed to 
MPharm undergraduate students who were present 
during their scheduled lecture sessions at LJMU. In 
total, 333 completed documents were received from 
this cohort, presenting a response rate of 79.2%. 
Participants included 204 females (61%) and 129 
males (39%). Here, the group included a reasonably 
even spread of students across Level 4 (24.6%), 
Level 5 (23.4%), Level 6 (27.6%) and Level 7 
(24.4%); the system that refers to student 
progression across the four years from entry (i.e. 
Level 4) to exit (i.e. Level 7). In terms of age, 95.2% 
of all questionnaires distributed were completed by 
students in the 18-29 years old bracket with 3.9% in 
the 30-39 age bracket and 0.9% in the 40-49 year 
old range. 
A total of 245 completed questionnaires were 
received from the community pharmacy cohort 
based in Manchester and Liverpool, thus providing 
a response rate of 49%. Participants included 125 
females (49%) and 120 males (51%). The 
respondents were categorised into 6 age groups; 
namely between 18 to 29 years (29.4%), between 
30 to 39 years (38%), between 40 to 49 years 
(16.7%), between 50 to 59 years (11.8%), between 
60 to 69 years (2.4%), and over 70 years (1.6%). 
The participants possessed a wide ranging level of 
experience, with 173 having practised for 10 years 
or less (70.7%) and followed by 72 participants 
having practised for 10 years or more (29.3%).  
In total, 400 completed questionnaires were 
received from the general public cohort. 
Approximately half of those invited to complete the 
research tool returned it. Of those who took a form, 
all returned it. Participants included 214 females 
(53.5%) and 186 males (46.5%). Individuals were 
between 18 and 40 years old (45.5%) and over 40 
years old (54.5%). For the purposes of this study, 
the former grouping shall be classed as the ‘young 
cohort’ and the latter grouping classed as the ‘old 
cohort’; with no offence intended. The younger 
group was classified as participants between 18 and 
40 years old since individuals in this group living in 
developed countries would have grown up with 
mobile technology and therefore more likely to be 
familiar with it. The participants were categorised 
depending on the highest level of education 
achieved; trade or vocational qualification (5%), 
GCSE (13.8%), A-Level (23.5%), undergraduate 
degree (35.5%) or post graduate degree (17.3%), 
the remaining 5% did not have any qualifications.  
Adherence strategies 
A number of well documented strategies exist to 
support patients with medication adherence. 
Accordingly, the participants from each cohort were 
asked what strategies they used / would 
recommend in supporting medication adherence. 
The data obtained from the general public in 
Liverpool City Centre are presented in Table 1.  
The data indicate that daily routine serves as the 
principal way in which those individuals surveyed 
remember to use their medication (54.1%). It is also 
apparent that within this particular cohort the 
reliance upon mobile apps is extremely low (1.5%). 
In a similar manner, the pharmacist cohort surveyed 
indicated that daily routine would be the most likely 
route to support adherence to medication regimens 
(51.4%), with written reminders in second place at 
17.6%. Again, the use of mobile apps to promote 
medication adherence was low within the 
pharmacist cohort, with only 2.4% of respondents 
agreeing that this would be a viable support 
mechanism. With respect to the student cohort a 
similar trend was noted.  
In this case, taking medicine as part of the daily 
routine was cited as the most common method to 
support adherence to prescribed medication 
regimens (47.4%). Whilst it was apparent that a 
relatively large proportion of students did not utilise 
a particular strategy to aid medication adherence 
(23.7%). Interestingly, only 3% of those surveyed 
used mobile apps as a current strategy to support 
adherence. 
Mobile app use to support medication 
adherence  
Within recent years, smartphone usage across the 
generations has increased significantly. In an 
attempt to establish whether there was a difference 
between older and younger generations and mobile 
app usage, participants were asked to consider how 
willing they would be to use / promote mobile apps 
to aid medication adherence. The data from the 
general public cohort is presented in Figure 1. 
The data presented in Figure 1 indicate that the 
young cohort would be more willing to use mobile 
apps to support medication adherence, a trend 
contrasting with the older respondents. In relation to 
this point, the pharmacist cohort was asked to 
consider whether patients might use mobile 
healthcare apps to help with adherence to 
medication. Here, those individuals surveyed 
suggested that they either agree (36.7%), neither 
Table 1. Approaches taken by the general public to 
adhere to prescribed medication regimens (n=400) 
Strategy % respondents 
Written reminders 4.8% 
Daily routine 54.1% 
Alarm 10.0% 
Family / Carer 19.6% 
Mobile apps 1.5% 
None 10.0% 
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agree or disagree (30.6%) or disagree (23.7%). The 
data is suggestive of a divide between the old and 
young cohorts to the acceptance / ability to use 
mobile healthcare apps to support healthcare. With 
reference to the student cohort, a total of 51.1% of 
those surveyed agreed (i.e. strongly agree or agree) 
to using mobile apps to support adherence to 
medication regimens with only 17.8% being 
opposed to the idea (i.e. strongly disagree and 
disagree).  
Monitoring health profiles with adherence apps / 
external devices 
As previously outlined, scope now exists to fuse 
mobile healthcare apps with external devices (i.e. 
smart patches) in order to monitor patient 
adherence to medication regimens. Innovations 
such as this hold the potential to support patients 
and health providers in monitoring medicines usage 
and related treatment outcomes. Consequently, 
participants were asked to consider their level of 
comfort in using / recommending external devices to 
aid the adherence process. The data obtained from 
the general public cohort is presented in Figure 2. 
The data presented in Figure 2 indicate that the 
younger participants within the general public cohort 
were comfortable in using an external device linked 
to a smartphone / table device when compared to 
the older participants. There is a clear divide in the 
data set which may be ascribed to the function of 
age. With respect to the pharmacist cohort, 86.2% 
of respondents indicated that they would be 
comfortable in recommending the use of an external 
device to monitor the level of patient adherence to 
prescribed medication.  
Figure 1. Willingness of the general public to use mobile apps to aid adherence as a function of age (n=400)
Figure 2.  Level of comfort expressed by the general public towards the use of an external 
device with an adherence app (n=400),
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In terms of the student cohort, consideration was 
given to the prospect of both using an external 
device located on their body to monitor adherence 
and a healthcare professional monitoring medicines 
usage with a mobile app. Here, 48.7% of Level 7 
students were comfortable in wearing an external 
device to monitor adherence, with 58.7% of 
students at Level 6 stating the same.  
Furthermore, of those students studying at Level 5 a 
total of 50% were comfortable in using an extra 
device and this number reduced to 30.4% in Level 
4. Those students who suggested that they would 
use a mobile app to aid adherence were statistically 
more likely to be comfortable in using an external 
device on part of their body to support the 
monitoring process (p=0.000) compared to those 
who would not. The majority of student participants 
(64.1%) were comfortable in such monitoring taking 
place by a healthcare professional. Overall, the data 
clearly demonstrate that there is a divide between 
the young and old age brackets towards the use 
and application of mobile healthcare apps to 
support medication adherence. 
Desirable traits of an adherence app 
The ideal characteristics of a mobile healthcare app 
to support medication adherence were determined 
by ranking six features in order of importance. 
Aspects for consideration included: ease of use, 
reliability and security, regulated information, cost, 
fun and impact on battery life. The data presented in 
Table 2 provide an overview of the pharmacists’ 
perceptions on these themes. 
The data presented in Table 2 demonstrate that the 
pharmacist cohort believed that the ease of use of a 
mobile app is the most important point to consider 
when using the platforms to promote / support 
medication adherence, followed by the cost of the 
app and reliability / security aspects. In a similar 
fashion, the results from the student cohort 
indicated that the most popular traits for a mobile 
healthcare app to support adherence were ease of 
use (34.6%) along with reliability and security 
(25.9%). It was also evident that the availability of 
regulated information was important (19.8%) and 
the cost of a mobile app was a key consideration 
(18.5%). In a similar manner to the general public 
cohort, the aspect of fun and the impact on battery 
life were given the lowest level of importance by the 
students. The data suggest that these trends were 
apparent through each of the Levels surveyed (i.e. 
from the more basic (Level 4) to the more advanced 
(Level 7)).  
 
Barriers to adherence app use 
In order to ascertain the barriers that might hinder 
the uptake and use of mobile healthcare apps to 
support medication adherence, each cohort was 
asked to highlight key concerns based on: technical 
difficulties, data usage, app security, app regulation 
and the reliability of information. The data obtained 
from the pharmacist cohort is presented in Table 3. 
Upon inspection of the data is it clear that the 
reliability of information, app security and technical 
difficulties are chief concerns amongst this cohort. 
In a similar manner, members of the general public 
suggested that both the reliability of information is a 
key concern (i.e. young cohort: 29.8% / old cohort: 
21.7%) as well as app security (i.e. young cohort: 
34.3% / old cohort: 27.6%). Interestingly, the older 
cohort within this group suggested that technical 
difficulties may present as a barrier to mobile app 
use (27.2%), whereas this was not important in the 
young cohort (3.9%). The student unit mirrored 
these concerns with app reliability (39.2%) and app 
security (27.8%) being of significance. Those 
concerns aired from this group included the fact that 
battery life may be affected and time is required for 
mHealth app use. 
Support mechanisms to enhance adherence app 
uptake 
In order to promote the uptake and use of mobile 
healthcare apps in the sphere of adherence to 
medication regimens, there may be a need to 
educate and train individuals on the use of 
healthcare apps. Here, the pharmacist cohort was 
asked to consider if they would be happy to help 
with the support of the patient in this field and the 
results are presented in Figure 3. 
The data demonstrate that the pharmacist cohort 
responded positively with 82.3% stating that they 
would be happy to train individuals on how to use 
mobile apps to support adherence. This figure 
reflects that expressed by those members of the 
general public surveyed in this study, where 84% 
indicated that they would be happy to receive 
training on the use of mobile health applications to 
support adherence to prescribed medication 
regimens. In addition, the student cohort was invited 
to consider whether they would be content to use a 
mobile healthcare app to aid adherence to 
medication regimens further to training from 
healthcare professionals. Here, a total of 70.4% of 
Level 7 students appeared happy to do so (i.e. very 
or quite happy). However, those students in Levels 
4, 5 and 6 demonstrated slight reservations in that 
52.5%, 58.7% and 57.6%, respectively, reported 
that they would be happy to receive such training. In 
general terms, it appears that there is a level of 
acceptance and satisfaction in using mobile apps to 
Table 2. Aspects of an adherence app considered 
important by the pharmacist cohort (n=245) 
Factor % respondents 
Ease of use 50.7% 
Reliability / Security 13.1% 
Regulated information 6.6% 
Cost 19.6% 
Fun 3.4% 
Impact on battery life 6.6% 
Table 3. Aspects of mobile app design considered 
important by the pharmacist cohort (n=254) 
Element % respondents 
Technical difficulties 26.1% 
The usage of data 4.5% 
Security of mobile apps 20.8% 
Regulation of mobile apps 13.5% 
Reliability of information 35.1% 
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aid medication adherence should sufficient training 
and support be provided by a healthcare 
professionals. 
 
DISCUSSION 
Recent developments in the field of mobile 
technology have led to a notable upsurge in 
software applications to support patient healthcare.3 
Potential now exists for mHealth apps to promote 
medication usage (i.e. adherence) thus leading to 
improved treatment outcomes and reduced 
medicines wastage. To date, a significant amount of 
work has been conducted within the sphere of 
mHealth in order to develop and appraise software 
apps plus the hardware to run them. However, so 
far, limited consideration has been given to the 
attitudes of those individuals who would either 
promote (i.e. qualified pharmacists / pharmacy 
undergraduates) or use (i.e. members of the 
general public) mobile apps to support healthcare 
needs and in particular the adherence to medication 
regimens. Therefore, this timely study has 
considered the potential for using mobile apps to 
support patient adherence to medication within the 
community setting. 
Strategies to support medication adherence 
The number of prescribed drugs, timing of 
administration, frequency of dosing along with the 
cost and duration of treatment can influence 
adherence to medication regimens.32 Further to 
these points, the data presented within this study 
indicates that daily routine is an important 
consideration. We would indeed expect this factor to 
be significant as the patient would be familiar in 
following a set routine, which would involve taking 
their medication during regular day-to-day activities. 
However, in reality, issues may arise to affect such 
regularity (i.e. ill health of a family member). On 
occasions such as this, mHealth apps may be 
recommended and used to support the patient with 
adherence to prescribed medication regimens (i.e. 
via reminder functionalities). However, it would 
appear that mHealth apps are seldom used to 
support medication adherence. It is likely that this 
tendency is associated with two key points; namely, 
patient awareness and education concerning 
mHealth apps. To address these pressing issues 
scope exists within the community pharmacy sector 
to promote mHealth apps and thus stimulate uptake 
and end use. Opportunity undoubtedly presents for 
the pharmacist to engage with patients and educate 
as to the function of mHealth apps. Here, several 
aspects would be important for consideration; 
namely, device type and appropriate training.  
We perceive no reason as to why mobile apps 
cannot contribute to supporting adherence to 
medication regimens on a daily basis in the future. 
A wide range of software applications (i.e. 160 or 
more) have been developed within recent years; 
prime examples include MyMeds and RxmindMe. 
These software packages employ reminder and 
alarm modalities to provide daily alerts based on 
individual requirements (i.e. for those who are 
forgetful, on complex medication regimens plus 
those who have cognitive impairment along with 
patient carers.8,33  
Willingness to use / promote mHealth apps to 
support medication adherence 
With the general public in mind, the younger 
respondents of those surveyed (i.e. individuals aged 
40 years or less) were positive towards the use of 
mHealth adherence apps when compared to the 
older cohort. Understandably, this finding may be 
related to the fact that younger individuals are 
accustomed to using mobile technology and are 
somewhat reliant on it for conducting daily activities. 
Therefore, it is expected that this group would be 
comfortable with incorporating mHealth apps to 
manage their medication (i.e. supporting 
adherence) on a daily basis. Indeed, it is important 
to highlight that several of the younger participants 
questioned currently utilise mHealth apps such as 
My Pill and Medisafe with a high degree of 
enthusiasm.  
Figure 3. Degree to which the pharmacist cohort would be happy to educate the patient in mobile 
app use (n=254)
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As noted, the older participants within this study (i.e. 
individuals aged 40 years or over) were significantly 
less receptive to using adherence apps. In fact, 
those individuals questioned cited that the platforms 
would not be helpful. If we consider the ‘Technology 
Acceptance Model’, the incentive to use mHealth 
apps stems from both the perceived specific 
benefits to the user and also the ease of use.34 It is 
highly probable that the older participants are too 
familiar with more traditional techniques for taking 
their medication and subsequently they do not 
recognise the usefulness of mHealth apps. This 
observation was similarly noted in the small scale 
study conducted by Lee and colleagues in 2014.29 
Here, interviews concerning mHealth technologies 
were conducted with 11 patients aged over 65 years 
taking anticoagulation medication. The group 
reported that participants believed mHealth apps to 
manage medication may be of value to other 
patients but not themselves because the majority of 
participants had been prescribed warfarin therapy 
for many years and therefore had developed 
suitable adherence strategies during that time. The 
older participants also stated that they found the 
concept of mHealth apps to be complicated. 
Although there are a large number of mHealth apps 
currently available to support the patient, such 
platforms may not be designed to account for age-
specific requirements. This population subgroup 
have needs that vary substantially from a younger 
population due to impaired vision, cognitive function 
and manual dexterity, for example.35 The perceived 
complex nature of adherence apps may have arisen 
due to the older subgroup presuming that the app 
would be too time-consuming, difficult to initiate and 
require a lot of data entry and management.  
Notwithstanding this notable trend, potential does 
exist for older individuals to utilise mobile 
technology to support their healthcare needs. For 
instance, in 2014 Mira and co-workers conducted a 
study involving 51 participants and analysed a 
medicine management app called ‘ALICE’.36 The 
data suggested that older patients with complex 
medication regimens, as well as limited experience 
in using smart devices or even computers, were still 
able to effectively use the adherence app. Here, it is 
important to note that the participants were provided 
with a relatively simple to use 7-inch platform 
device, attended a two hour app training session 
and had convenient access to a technical support 
number; thus a positive outcome was anticipated. 
We believe approaches such as these could be 
readily implemented within the community 
pharmacy sector and thus afford great benefit to the 
general public as a whole, regardless of age. Well-
designed and supported adherence apps would 
allow for ease of use by all age groups.  
Pharmacists within the community setting are well-
placed to provide such training and the data 
presented herein indicate that those surveyed would 
be happy to help the patient in using mHealth 
adherence apps. Clearly, a well-informed supporting 
framework is required going forward in order to 
enhance uptake of the technology platforms. Here, 
pharmacists may have the opportunity to reverse 
erroneous misperceptions as well as increase 
awareness of adherence apps among their patients 
by providing patient education through seminars, 
leaflets and individual consultations on available 
apps, how they are used, how to access technical 
support and information on the relative benefits the 
technology brings. With regard to pharmacist 
remuneration for mHealth service provision in the 
UK, providers could be locally commissioned to 
offer an enhanced service to members of the 
general public. Within the UK, the clinical 
commissioning group (CCG) model may be applied 
to provide a mHealth service to the local community 
for a financial reward.37 Additional routes for 
reimbursement in the UK may involve accessing 
local authority or local NHS England team funds. 
For instance, these approaches could be applied in 
the case of the Helius platform as detailed 
previously. Payment to the pharmacy could be 
claimed after a follow-up consultation once the app 
and equipment have been set up. In a similar 
manner to existing enhanced services (i.e. Inhaler 
Technique Review and Training), implementation of 
an adherence app service is likely to be a practical 
approach to improving public health and reducing 
medicine wastage. 
Monitoring and use of external devices to aid 
adherence to prescribed medication 
In terms of the general public surveyed within this 
study, there was once again a clear divide in age 
when consideration was given to the level of 
comfort in medication use being monitored by a 
healthcare professional via a mobile app. We 
believe that the same rationale as previously 
provided regarding age-related patient uptake of 
mHealth may be applied here. Interestingly, in 2013 
Dayer and co-workers determined that data sharing 
between patients and healthcare providers was 
indeed valued.8 It is reasonable to propose, 
therefore, that patients assign a level of importance 
in having open and effective communication with 
their healthcare provider. There is a perceived level 
of benefit of treatment monitoring as useful for 
general wellbeing, with an added benefit of the 
reassurance available to answer queries. In order to 
secure effective mHealth app uptake within the 
community setting it is this point that needs to be 
built on and developed. Perhaps the personalisation 
this approach brings could augment adherence to 
prescribed regimens by providing motivation and 
enhanced support. 
Increasing demands on healthcare provider time 
within developed countries (i.e. the UK and USA) 
often make it challenging to sustain frequent face-
to-face communication with those patients who 
require regular monitoring or those who find 
adherence difficult.38 Consequently, patients may 
experience negative health effects, thereby 
increasing pressure on related healthcare services. 
Innovative technology platforms offer a means by 
which to solve these issues by enabling patient 
information to be readily accessible by healthcare 
professionals to review and then respond in a more 
streamlined manner.38 On the other hand, frequent 
communication with healthcare professionals via 
mHealth strategies may exert additional workload 
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pressures (i.e. due to the combination of dealing 
with patients remotely as well as those in person 
within the same timeframe of a working day). For 
instance, DiDonato and co-workers noted 
apprehension with this arrangement as 
communication via mobile apps was perceived to 
increase the workload of pharmacists.39 Over the 
course of recent years within the UK, time 
pressures within community pharmacy have steadily 
increased due to increased prescription volume and 
the growing number of advanced (i.e. appliance use 
review) and enhanced (i.e. supervised medication 
consumption) services offered. Thus, pharmacists 
may find incorporating adherence app management 
into their practice particularly challenging.  
In terms of the student cohort, a mixed reception to 
the use of an external device to monitor medication 
adherence patterns was apparent. Overall, there 
was a general acceptance of the concept. However, 
the data suggest that the Level 4 students were 
rather unimpressed with the approach with this 
viewpoint changing as the years developed. We are 
of the view that those students positioned towards 
the end of their studies would have a cumulative 
knowledge and a great deal of experience of 
medication usage plus the benefit of patients to 
adhering to prescribed regimens effectively, thus 
would be more likely to consider the associated 
practicalities in a more positive and pro-active 
manner. Naturally, this approach would feed into 
professional life upon qualification and as practising 
pharmacists the individuals would strive towards 
high standards and accordingly support patients in 
the management of disease (i.e. to monitor and 
track adherence). Leading on from this, the vast 
majority of pharmacists surveyed within this study 
were comfortable in recommending a mHealth app 
and an external monitoring device to promote 
medication adherence. We suggest that those 
respondents feel monitoring patient adherence and 
treatment outcomes are very important routes to 
assure and sustain an optimal quality of life. 
Remarkably, workload pressures were not stated as 
a barrier to monitoring patient adherence by the 
pharmacist cohort. Here, we suggest that the 
benefits associated with such monitoring would 
outweigh the perceived increase in pressure.  
Perceived barriers to mobile app uptake and 
methods to circumvent 
Healthcare apps are evidently becoming 
increasingly popular amongst the healthcare 
community and public, alike. Nevertheless, several 
concerns appear to exist that might hinder future 
uptake. To ensure mHealth apps are successful 
such concerns need to be addressed in a pro-active 
manner. Amongst all cohorts key concerns 
surrounding mHealth app use included data 
reliability and regulation, app security plus ease of 
use.  
The ability of a mHealth app to provide reliable 
information was regarded as essential by the 
general public surveyed within this study. We 
attribute this finding to the fact that such software 
platforms may be the basis on which critical 
decisions concerning their healthcare are made.28 
Clearly, in order for reliable information to be 
provided there needs to be strict regulation within 
the field. Such regulation would overcome safety 
issues that may arise as a result of the lack of 
medical training of some app developers and 
thereby increase the confidence that reliable 
information is present.28 Furthermore, as previously 
alluded to, there is currently a large number of 
mHealth apps on the market which can lead to 
confusion amongst patients leading to the issue of 
which one(s) to trust.40 Here, the endorsement of a 
number of regulated mHealth apps would be a 
suitable route to follow to stimulate public 
acceptance and thus promote the uptake of these 
technologies. In terms of mHealth app uptake and 
acceptability within the general population, we 
suggest that those individuals who are generally 
adherent to their medication will be more accepting 
of the technology platforms because they have the 
understanding and behaviour engrained within them 
to derive the maximum benefit from the range of 
support mechanisms available. Whereas those 
individuals who do not routinely adhere to 
prescribed medication regimens are likely not to be 
adherent or open to mHealth app software for 
support. In the case of this latter population 
subgroup, patient education is key and assistance 
to establish mHealth apps on their chosen device 
would be extremely important. Once a mHealth app 
is established on a portable device, in general there 
would be no requirements for further interventions 
and thus regular prompts / advice may be received 
by the patient to encourage medication adherence. 
Interestingly, in 2014 The Food and Drug 
Administration (FDA) released a guidance 
document in relation to the regulation of medical 
apps.31 The organisation highlighted that some 
apps may be classified as ‘high-risk’, including 
those that transform the mobile platform (i.e. 
smartphone / tablet device) into a medical device.40 
To date, within the UK and USA markets a risk 
assessment framework does not exist and it is not 
always clear if a particular app is classed as a 
‘medical device’. Naturally, these points can lend 
confusion to the scene over which apps actually 
need to be regulated.28 In relation to these points, 
attempts have taken place to regulate mHealth 
apps. For example, within the UK the NHS has 
established an online ‘Health Apps Library’ which 
provides recommendations for specific apps and 
many are anticipating the NHS creating a ‘vetted 
app store’ to ensure the quality of mHealth apps.31 
As per other groups within this study, the student 
cohort considered that mHealth apps should be 
regulated by a professional body. With this, any 
changes or updates to information and guidance 
should be regular and quick to access. A model 
example of this is the National Institute for Health 
and Care Excellence (NICE) mobile app platform. 
Here, published NICE guidelines are regularly 
updated and the app automatically receives updates 
when new guidelines are released.41  
In a similar manner to the general public, those 
pharmacists surveyed indicated that the major issue 
with mHealth apps is the concern over data 
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reliability. To overcome this issue and improve 
acceptance of the technology platforms amongst 
the healthcare community, we suggest that medical 
professionals should be involved during all stages of 
app development as detailed by Visser and co-
workers in 2012.42 Moreover, peer review of 
mHealth apps would offer an effective means to 
ensure data accuracy and thus applicability within 
the medical community and general public, alike. It 
is interesting to note that the pharmacist cohort 
believed that the general public would indeed be 
comfortable in using mHealth apps if they were 
promoted by healthcare professionals. In point of 
fact, the finding links well with previous research, 
with those mHealth apps developed by healthcare 
organizations being rated higher on the patient 
comfort score.43  
Naturally, such healthcare apps could be designed 
and developed in-house by independent / large 
chain retailers. Here, healthcare organisations 
would have the flexibility to drive software 
development and introduce their own views as to 
what is important for mHealth app usage. This is a 
clear area for further investigation. Within such 
work, a key question would be whether the mHealth 
apps should be standard and follow a prescriptive 
approach or if they should be tailored directly to the 
business requirements of the individual outlet.  
A key attribute of mHealth apps is the ability to 
collect and transmit personal information (i.e. daily 
activities and health status).31 Whilst this is 
advantageous in certain circumstances (i.e. during 
the monitoring of adherence to medication 
regimens), concern exists with regard to the security 
of the app and who might have access to this data. 
To circumvent such unease, technological 
advances have been made. For instance, there has 
been a recent introduction of biometric fingerprint 
identification in some mobile devices which may be 
able to offer reassurance with this regard by being 
able to confirm identity without the hassle of 
entering a manual passcode.40 Furthermore, the 
patient’s account could automatically be configured 
to log out after a few minutes of inactivity to prevent 
fraudulent use. Moreover, several individuals 
surveyed here were particularly concerned about 
app developers selling personal data to third parties 
(i.e. insurance companies) and consequentially 
being subjected to increased premium rates. 
Positive steps may be taken to counter this concern, 
for instance certain app stores (i.e. Apple) have 
tightened their privacy policies to prohibit the sale of 
data.44  
Both age groups within the general public cohort 
indicated that technical aspects surrounding mobile 
platforms stood as a barrier to end use, albeit for 
different reasons. With regard to the younger 
participants questioned, concerns were aired over 
volume of data the app would use, which would 
ultimately impact upon costings and the network 
plan. However, arguably more important, the older 
cohort was anxious with regard to experiencing 
technical difficulties with mHealth apps and the 
physical technology platform itself.  
The latter point is significant because should 
medically accurate and highly-regulated apps be 
released onto the marketplace, limited benefit would 
be derived should technical / use difficulties arise 
and not overcome. The respondents were also 
anxious about app / device set up, troubleshooting 
should malfunctions arise and the possibility of not 
understanding the content presented. In order to 
circumvent these issues, targeted training (i.e. 
background overview plus use and maintenance of 
the technology) could be executed within 
community pharmacy premises as detailed 
previously.  
Furthermore, in a similar fashion as the other 
cohorts studied herein, the student body believed 
that training is essential for mHealth apps to really 
have an impact on patient healthcare. Here, it is 
appropriate to consider the inclusion of mHealth app 
training within the MPharm degree in order to equip 
the pharmacists of the future with the skills 
necessary to promote and train members of the 
general public on the use of mHealth apps. In this 
case, provision within the undergraduate timetable 
could be made for both theoretical and practical 
aspects surrounding mHealth (i.e. the technology 
platforms and how they may best serve healthcare 
needs) in order to familiarise students progressing 
through the MPharm degree.  
Limitations 
The data generated within this study provide an 
insight into the opinions held by UK registered 
pharmacists, pharmacy undergraduates and the 
general public in the Liverpool region towards the 
use of mHealth technology to aid medication 
adherence. Whilst clear trends are evident within 
the results, caution must be exercised in terms of 
generalisability for more developed populations (i.e. 
the UK and USA) as a whole. As the sample size 
was relatively small and from the North West of 
England the applicability to other parts of the 
country, and indeed overseas, may be questioned. 
Therefore, we highlight the fact that only general 
predictions may be allocated to the themes 
presented within this piece. As mHealth platforms 
are becoming ever more popular and clearly 
infiltrating into society there is a pressure to view 
the platforms in a positive manner during 
discussion. The data presented within this cross-
sectional survey may involve an element of social 
desire bias that will ultimately influence patterns 
within the presented data. An additional factor for 
consideration involves the possibility of respondent 
fatigue and as such a general non-commitment to 
some of the questions posed during the interview 
process. Such responses can result in a degree of 
impartiality on a specific theme, which can skew the 
data set acquired and hence related description. 
 
CONCLUSIONS 
The evolution of smartphone and tablet device 
technology has impacted all areas of society, 
including the sphere of healthcare. Potential now 
exists to download and install mHealth apps which 
may connect to monitoring platforms and ultimately 
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support patient adherence to prescribed regimens. 
The acceptance and uptake of such technologies 
will be dependent upon aspects such as individual 
preparedness to use a mHealth app as a function of 
age, suitable promotion and education strategies 
plus appropriate regulation. The latter point is 
pivotal to initiate a paradigm shift. This is so as 
effective regulatory control and the standardisation 
of mHealth apps will eliminate the reluctance of 
pharmacists in promoting the technology and 
likewise stimulate patient-end use. Further work to 
compare the more traditional methods to support 
medication adherence and advanced strategies will 
be of great value within this field of healthcare. With 
more detailed investigation and development plus 
related management and assistance, we envisage a 
point in time where mHealth strategies (i.e. the 
promotion of medication adherence) will hold a 
prominent position within the field of healthcare and 
naturally bring benefit to the wider public health as a 
whole.  
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ACTITUDES DE LOS FARMACÉUTICOS, 
ESTUDIANTES Y PUBLICO EN GENERAL 
SOBRE APLICACIONES DE mHEALTH PARA 
ADHERENCIA A LA MEDICACIÓN 
 
RESUMEN 
Antecedentes: Durante los últimos años, la tecnología 
móvil se ha desarrollado enormemente y se ha infiltrado 
en el campo de la salud. Las aplicaciones, o apps, de 
sanidad móvil (mHealth) pueden usarse para apoyar la 
adherencia del paciente a la medicación y así promover 
los resultados óptimos del tratamiento y reducir el 
desperdicio de medicamentos. 
Objetivo: Este estudio considerará las opiniones de los 
farmacéuticos, estudiantes de farmacia, y público en 
general del Reino Unido (UK) sobre el uso de apps de 
mHealth para promover la adherencia a los regímenes de 
medicación prescritos. 
Métodos: Después de aprobación ética por la Liverpool 
John Moores University (LJMU), se distribuyó el 
cuestionario de 25 ítems entre los farmacéuticos 
registrados en las ciudades de Liverpool y Manchester 
(n=500), estudiantes de farmacia de la LJMU (n=420), y 
miembros del público en general en el centro de la ciudad 
de Liverpool (n=400). Las preguntas estaban formateadas 
en una escala Likert de selección múltiple o en respuestas 
abiertas. Se analizaron los datos utilizando frecuencias 
simples, tablas cruzadas, y pruebas no paramétricas en el 
programa SPSS v22. 
Resultados: El número de cuestionarios completados por 
los farmacéuticos, estudiantes de farmacia y público en 
general fue de 245, 333 y 400; respectivamente. Los 
datos indicaron que el público general confiaba 
fuertemente en la rutina diaria de tomar la medicación 
como fue prescrita (54,1%), con un uso de apps de 
mHealth extremamente bajo (1,5%); tendencias similares 
se encontraron en las cohortes de farmacéuticos / 
estudiantes de farmacia. La edad de los individuos es un 
elemento importante a considerar, con la generación más 
joven proclive a envolverse con apps de mHealth y una 
generación mayor menos proclive. Aquí, la educación y 
la formación son importantes. Los farmacéuticos (82,3%) 
estarían de a favor de proporcionar paquetes de 
formación al público que a cambio está de acuerdo en 
recibir esa formación (84%). Las principales barreras que 
impiden el uso de apps de mHealth incluyen la fiabilidad 
de los datos, la seguridad y las dificultades técnicas. 
Conclusión: Las apps de adherencia son una gran 
promesa para apoyar al paciente y sus necesidades de 
salud. Para aumentar la aceptación y la adopción, deben 
considerarse y construirse diseños simples y amigables. 
Además, esta tecnología requiere promoción efectiva y 
formación del usuario final para alcanzar su potencial 
completo. Por último, será esencial la regulación de las 
apps de adherencia para sobrepasar las preocupaciones 
subyacentes de los pacientes. 
 
Palabras clave: Teléfonos Celulares; Computadores de 
Bolsillo; Cumplimiento de la Medicación; Preferencias 
del Paciente; Farmacéuticos; Cuestionarios; Reino Unido 
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